Translational Development Acquisition ratios data for the quarter ended Jun 2026. These financial ratios cover 8 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2023 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|
| Efficiency | ||||||||
| Assets AverageAssets Avg. | 175.80M | 177.39M | 179.08M | 180.84M | 182.52M | 170.36M | ||
| Invested CapitalInvested Cap. | -0.16M | -5.60M | -6.28M | -6.34M | -6.32M | -6.58M | ||
| Leverage & Solvency | ||||||||
| Debt Ratio | 171.94 | 0.00 | 0.00 | 0.00 | 0.01 | |||
| Return Ratios | ||||||||
| Return on Capital Employed [ROCE]ROCE | -0.43% | -0.51% | -0.52% | -0.48% | -0.78% | |||
| Return on Assets [ROA]ROA | -0.43% | -0.51% | -0.52% | -0.48% | -0.77% |